Request for Covid-19 Impact Assessment of this Report
The United States Methylphenidate market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Methylphenidate market, reaching US$ million by the year 2028. As for the Europe Methylphenidate landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Methylphenidate players cover Pfizer, Teva, Novartis, and Sandoz, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Methylphenidate market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Tablet
Capsule
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Attention deficit hyperactivity disorder
Narcolepsy
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Pfizer
Teva
Novartis
Sandoz
GSK
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Methylphenidate Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Methylphenidate by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Methylphenidate by Country/Region, 2017, 2022 & 2028
2.2 Methylphenidate Segment by Type
2.2.1 Tablet
2.2.2 Capsule
2.2.3 Others
2.3 Methylphenidate Sales by Type
2.3.1 Global Methylphenidate Sales Market Share by Type (2017-2022)
2.3.2 Global Methylphenidate Revenue and Market Share by Type (2017-2022)
2.3.3 Global Methylphenidate Sale Price by Type (2017-2022)
2.4 Methylphenidate Segment by Application
2.4.1 Attention deficit hyperactivity disorder
2.4.2 Narcolepsy
2.4.3 Other
2.5 Methylphenidate Sales by Application
2.5.1 Global Methylphenidate Sale Market Share by Application (2017-2022)
2.5.2 Global Methylphenidate Revenue and Market Share by Application (2017-2022)
2.5.3 Global Methylphenidate Sale Price by Application (2017-2022)
3 Global Methylphenidate by Company
3.1 Global Methylphenidate Breakdown Data by Company
3.1.1 Global Methylphenidate Annual Sales by Company (2020-2022)
3.1.2 Global Methylphenidate Sales Market Share by Company (2020-2022)
3.2 Global Methylphenidate Annual Revenue by Company (2020-2022)
3.2.1 Global Methylphenidate Revenue by Company (2020-2022)
3.2.2 Global Methylphenidate Revenue Market Share by Company (2020-2022)
3.3 Global Methylphenidate Sale Price by Company
3.4 Key Manufacturers Methylphenidate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Methylphenidate Product Location Distribution
3.4.2 Players Methylphenidate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Methylphenidate by Geographic Region
4.1 World Historic Methylphenidate Market Size by Geographic Region (2017-2022)
4.1.1 Global Methylphenidate Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Methylphenidate Annual Revenue by Geographic Region
4.2 World Historic Methylphenidate Market Size by Country/Region (2017-2022)
4.2.1 Global Methylphenidate Annual Sales by Country/Region (2017-2022)
4.2.2 Global Methylphenidate Annual Revenue by Country/Region
4.3 Americas Methylphenidate Sales Growth
4.4 APAC Methylphenidate Sales Growth
4.5 Europe Methylphenidate Sales Growth
4.6 Middle East & Africa Methylphenidate Sales Growth
5 Americas
5.1 Americas Methylphenidate Sales by Country
5.1.1 Americas Methylphenidate Sales by Country (2017-2022)
5.1.2 Americas Methylphenidate Revenue by Country (2017-2022)
5.2 Americas Methylphenidate Sales by Type
5.3 Americas Methylphenidate Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Methylphenidate Sales by Region
6.1.1 APAC Methylphenidate Sales by Region (2017-2022)
6.1.2 APAC Methylphenidate Revenue by Region (2017-2022)
6.2 APAC Methylphenidate Sales by Type
6.3 APAC Methylphenidate Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Methylphenidate by Country
7.1.1 Europe Methylphenidate Sales by Country (2017-2022)
7.1.2 Europe Methylphenidate Revenue by Country (2017-2022)
7.2 Europe Methylphenidate Sales by Type
7.3 Europe Methylphenidate Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Methylphenidate by Country
8.1.1 Middle East & Africa Methylphenidate Sales by Country (2017-2022)
8.1.2 Middle East & Africa Methylphenidate Revenue by Country (2017-2022)
8.2 Middle East & Africa Methylphenidate Sales by Type
8.3 Middle East & Africa Methylphenidate Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Methylphenidate
10.3 Manufacturing Process Analysis of Methylphenidate
10.4 Industry Chain Structure of Methylphenidate
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Methylphenidate Distributors
11.3 Methylphenidate Customer
12 World Forecast Review for Methylphenidate by Geographic Region
12.1 Global Methylphenidate Market Size Forecast by Region
12.1.1 Global Methylphenidate Forecast by Region (2023-2028)
12.1.2 Global Methylphenidate Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Methylphenidate Forecast by Type
12.7 Global Methylphenidate Forecast by Application
13 Key Players Analysis
13.1 Pfizer
13.1.1 Pfizer Company Information
13.1.2 Pfizer Methylphenidate Product Offered
13.1.3 Pfizer Methylphenidate Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 Pfizer Main Business Overview
13.1.5 Pfizer Latest Developments
13.2 Teva
13.2.1 Teva Company Information
13.2.2 Teva Methylphenidate Product Offered
13.2.3 Teva Methylphenidate Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Teva Main Business Overview
13.2.5 Teva Latest Developments
13.3 Novartis
13.3.1 Novartis Company Information
13.3.2 Novartis Methylphenidate Product Offered
13.3.3 Novartis Methylphenidate Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Novartis Main Business Overview
13.3.5 Novartis Latest Developments
13.4 Sandoz
13.4.1 Sandoz Company Information
13.4.2 Sandoz Methylphenidate Product Offered
13.4.3 Sandoz Methylphenidate Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Sandoz Main Business Overview
13.4.5 Sandoz Latest Developments
13.5 GSK
13.5.1 GSK Company Information
13.5.2 GSK Methylphenidate Product Offered
13.5.3 GSK Methylphenidate Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 GSK Main Business Overview
13.5.5 GSK Latest Developments
14 Research Findings and Conclusion
Table 1. Methylphenidate Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Methylphenidate Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of Tablet
Table 4. Major Players of Capsule
Table 5. Major Players of Others
Table 6. Global Methylphenidate Sales by Type (2017-2022) & (K MT)
Table 7. Global Methylphenidate Sales Market Share by Type (2017-2022)
Table 8. Global Methylphenidate Revenue by Type (2017-2022) & ($ million)
Table 9. Global Methylphenidate Revenue Market Share by Type (2017-2022)
Table 10. Global Methylphenidate Sale Price by Type (2017-2022) & (USD/MT)
Table 11. Global Methylphenidate Sales by Application (2017-2022) & (K MT)
Table 12. Global Methylphenidate Sales Market Share by Application (2017-2022)
Table 13. Global Methylphenidate Revenue by Application (2017-2022)
Table 14. Global Methylphenidate Revenue Market Share by Application (2017-2022)
Table 15. Global Methylphenidate Sale Price by Application (2017-2022) & (USD/MT)
Table 16. Global Methylphenidate Sales by Company (2020-2022) & (K MT)
Table 17. Global Methylphenidate Sales Market Share by Company (2020-2022)
Table 18. Global Methylphenidate Revenue by Company (2020-2022) ($ Millions)
Table 19. Global Methylphenidate Revenue Market Share by Company (2020-2022)
Table 20. Global Methylphenidate Sale Price by Company (2020-2022) & (USD/MT)
Table 21. Key Manufacturers Methylphenidate Producing Area Distribution and Sales Area
Table 22. Players Methylphenidate Products Offered
Table 23. Methylphenidate Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 24. New Products and Potential Entrants
Table 25. Mergers & Acquisitions, Expansion
Table 26. Global Methylphenidate Sales by Geographic Region (2017-2022) & (K MT)
Table 27. Global Methylphenidate Sales Market Share Geographic Region (2017-2022)
Table 28. Global Methylphenidate Revenue by Geographic Region (2017-2022) & ($ millions)
Table 29. Global Methylphenidate Revenue Market Share by Geographic Region (2017-2022)
Table 30. Global Methylphenidate Sales by Country/Region (2017-2022) & (K MT)
Table 31. Global Methylphenidate Sales Market Share by Country/Region (2017-2022)
Table 32. Global Methylphenidate Revenue by Country/Region (2017-2022) & ($ millions)
Table 33. Global Methylphenidate Revenue Market Share by Country/Region (2017-2022)
Table 34. Americas Methylphenidate Sales by Country (2017-2022) & (K MT)
Table 35. Americas Methylphenidate Sales Market Share by Country (2017-2022)
Table 36. Americas Methylphenidate Revenue by Country (2017-2022) & ($ Millions)
Table 37. Americas Methylphenidate Revenue Market Share by Country (2017-2022)
Table 38. Americas Methylphenidate Sales by Type (2017-2022) & (K MT)
Table 39. Americas Methylphenidate Sales Market Share by Type (2017-2022)
Table 40. Americas Methylphenidate Sales by Application (2017-2022) & (K MT)
Table 41. Americas Methylphenidate Sales Market Share by Application (2017-2022)
Table 42. APAC Methylphenidate Sales by Region (2017-2022) & (K MT)
Table 43. APAC Methylphenidate Sales Market Share by Region (2017-2022)
Table 44. APAC Methylphenidate Revenue by Region (2017-2022) & ($ Millions)
Table 45. APAC Methylphenidate Revenue Market Share by Region (2017-2022)
Table 46. APAC Methylphenidate Sales by Type (2017-2022) & (K MT)
Table 47. APAC Methylphenidate Sales Market Share by Type (2017-2022)
Table 48. APAC Methylphenidate Sales by Application (2017-2022) & (K MT)
Table 49. APAC Methylphenidate Sales Market Share by Application (2017-2022)
Table 50. Europe Methylphenidate Sales by Country (2017-2022) & (K MT)
Table 51. Europe Methylphenidate Sales Market Share by Country (2017-2022)
Table 52. Europe Methylphenidate Revenue by Country (2017-2022) & ($ Millions)
Table 53. Europe Methylphenidate Revenue Market Share by Country (2017-2022)
Table 54. Europe Methylphenidate Sales by Type (2017-2022) & (K MT)
Table 55. Europe Methylphenidate Sales Market Share by Type (2017-2022)
Table 56. Europe Methylphenidate Sales by Application (2017-2022) & (K MT)
Table 57. Europe Methylphenidate Sales Market Share by Application (2017-2022)
Table 58. Middle East & Africa Methylphenidate Sales by Country (2017-2022) & (K MT)
Table 59. Middle East & Africa Methylphenidate Sales Market Share by Country (2017-2022)
Table 60. Middle East & Africa Methylphenidate Revenue by Country (2017-2022) & ($ Millions)
Table 61. Middle East & Africa Methylphenidate Revenue Market Share by Country (2017-2022)
Table 62. Middle East & Africa Methylphenidate Sales by Type (2017-2022) & (K MT)
Table 63. Middle East & Africa Methylphenidate Sales Market Share by Type (2017-2022)
Table 64. Middle East & Africa Methylphenidate Sales by Application (2017-2022) & (K MT)
Table 65. Middle East & Africa Methylphenidate Sales Market Share by Application (2017-2022)
Table 66. Key Market Drivers & Growth Opportunities of Methylphenidate
Table 67. Key Market Challenges & Risks of Methylphenidate
Table 68. Key Industry Trends of Methylphenidate
Table 69. Methylphenidate Raw Material
Table 70. Key Suppliers of Raw Materials
Table 71. Methylphenidate Distributors List
Table 72. Methylphenidate Customer List
Table 73. Global Methylphenidate Sales Forecast by Region (2023-2028) & (K MT)
Table 74. Global Methylphenidate Sales Market Forecast by Region
Table 75. Global Methylphenidate Revenue Forecast by Region (2023-2028) & ($ millions)
Table 76. Global Methylphenidate Revenue Market Share Forecast by Region (2023-2028)
Table 77. Americas Methylphenidate Sales Forecast by Country (2023-2028) & (K MT)
Table 78. Americas Methylphenidate Revenue Forecast by Country (2023-2028) & ($ millions)
Table 79. APAC Methylphenidate Sales Forecast by Region (2023-2028) & (K MT)
Table 80. APAC Methylphenidate Revenue Forecast by Region (2023-2028) & ($ millions)
Table 81. Europe Methylphenidate Sales Forecast by Country (2023-2028) & (K MT)
Table 82. Europe Methylphenidate Revenue Forecast by Country (2023-2028) & ($ millions)
Table 83. Middle East & Africa Methylphenidate Sales Forecast by Country (2023-2028) & (K MT)
Table 84. Middle East & Africa Methylphenidate Revenue Forecast by Country (2023-2028) & ($ millions)
Table 85. Global Methylphenidate Sales Forecast by Type (2023-2028) & (K MT)
Table 86. Global Methylphenidate Sales Market Share Forecast by Type (2023-2028)
Table 87. Global Methylphenidate Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 88. Global Methylphenidate Revenue Market Share Forecast by Type (2023-2028)
Table 89. Global Methylphenidate Sales Forecast by Application (2023-2028) & (K MT)
Table 90. Global Methylphenidate Sales Market Share Forecast by Application (2023-2028)
Table 91. Global Methylphenidate Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 92. Global Methylphenidate Revenue Market Share Forecast by Application (2023-2028)
Table 93. Pfizer Basic Information, Methylphenidate Manufacturing Base, Sales Area and Its Competitors
Table 94. Pfizer Methylphenidate Product Offered
Table 95. Pfizer Methylphenidate Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 96. Pfizer Main Business
Table 97. Pfizer Latest Developments
Table 98. Teva Basic Information, Methylphenidate Manufacturing Base, Sales Area and Its Competitors
Table 99. Teva Methylphenidate Product Offered
Table 100. Teva Methylphenidate Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 101. Teva Main Business
Table 102. Teva Latest Developments
Table 103. Novartis Basic Information, Methylphenidate Manufacturing Base, Sales Area and Its Competitors
Table 104. Novartis Methylphenidate Product Offered
Table 105. Novartis Methylphenidate Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 106. Novartis Main Business
Table 107. Novartis Latest Developments
Table 108. Sandoz Basic Information, Methylphenidate Manufacturing Base, Sales Area and Its Competitors
Table 109. Sandoz Methylphenidate Product Offered
Table 110. Sandoz Methylphenidate Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 111. Sandoz Main Business
Table 112. Sandoz Latest Developments
Table 113. GSK Basic Information, Methylphenidate Manufacturing Base, Sales Area and Its Competitors
Table 114. GSK Methylphenidate Product Offered
Table 115. GSK Methylphenidate Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 116. GSK Main Business
Table 117. GSK Latest Developments
List of Figures
Figure 1. Picture of Methylphenidate
Figure 2. Methylphenidate Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Methylphenidate Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Methylphenidate Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Methylphenidate Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of Tablet
Figure 10. Product Picture of Capsule
Figure 11. Product Picture of Others
Figure 12. Global Methylphenidate Sales Market Share by Type in 2021
Figure 13. Global Methylphenidate Revenue Market Share by Type (2017-2022)
Figure 14. Methylphenidate Consumed in Attention deficit hyperactivity disorder
Figure 15. Global Methylphenidate Market: Attention deficit hyperactivity disorder (2017-2022) & (K MT)
Figure 16. Methylphenidate Consumed in Narcolepsy
Figure 17. Global Methylphenidate Market: Narcolepsy (2017-2022) & (K MT)
Figure 18. Methylphenidate Consumed in Other
Figure 19. Global Methylphenidate Market: Other (2017-2022) & (K MT)
Figure 20. Global Methylphenidate Sales Market Share by Application (2017-2022)
Figure 21. Global Methylphenidate Revenue Market Share by Application in 2021
Figure 22. Methylphenidate Revenue Market by Company in 2021 ($ Million)
Figure 23. Global Methylphenidate Revenue Market Share by Company in 2021
Figure 24. Global Methylphenidate Sales Market Share by Geographic Region (2017-2022)
Figure 25. Global Methylphenidate Revenue Market Share by Geographic Region in 2021
Figure 26. Global Methylphenidate Sales Market Share by Region (2017-2022)
Figure 27. Global Methylphenidate Revenue Market Share by Country/Region in 2021
Figure 28. Americas Methylphenidate Sales 2017-2022 (K MT)
Figure 29. Americas Methylphenidate Revenue 2017-2022 ($ Millions)
Figure 30. APAC Methylphenidate Sales 2017-2022 (K MT)
Figure 31. APAC Methylphenidate Revenue 2017-2022 ($ Millions)
Figure 32. Europe Methylphenidate Sales 2017-2022 (K MT)
Figure 33. Europe Methylphenidate Revenue 2017-2022 ($ Millions)
Figure 34. Middle East & Africa Methylphenidate Sales 2017-2022 (K MT)
Figure 35. Middle East & Africa Methylphenidate Revenue 2017-2022 ($ Millions)
Figure 36. Americas Methylphenidate Sales Market Share by Country in 2021
Figure 37. Americas Methylphenidate Revenue Market Share by Country in 2021
Figure 38. United States Methylphenidate Revenue Growth 2017-2022 ($ Millions)
Figure 39. Canada Methylphenidate Revenue Growth 2017-2022 ($ Millions)
Figure 40. Mexico Methylphenidate Revenue Growth 2017-2022 ($ Millions)
Figure 41. Brazil Methylphenidate Revenue Growth 2017-2022 ($ Millions)
Figure 42. APAC Methylphenidate Sales Market Share by Region in 2021
Figure 43. APAC Methylphenidate Revenue Market Share by Regions in 2021
Figure 44. China Methylphenidate Revenue Growth 2017-2022 ($ Millions)
Figure 45. Japan Methylphenidate Revenue Growth 2017-2022 ($ Millions)
Figure 46. South Korea Methylphenidate Revenue Growth 2017-2022 ($ Millions)
Figure 47. Southeast Asia Methylphenidate Revenue Growth 2017-2022 ($ Millions)
Figure 48. India Methylphenidate Revenue Growth 2017-2022 ($ Millions)
Figure 49. Australia Methylphenidate Revenue Growth 2017-2022 ($ Millions)
Figure 50. Europe Methylphenidate Sales Market Share by Country in 2021
Figure 51. Europe Methylphenidate Revenue Market Share by Country in 2021
Figure 52. Germany Methylphenidate Revenue Growth 2017-2022 ($ Millions)
Figure 53. France Methylphenidate Revenue Growth 2017-2022 ($ Millions)
Figure 54. UK Methylphenidate Revenue Growth 2017-2022 ($ Millions)
Figure 55. Italy Methylphenidate Revenue Growth 2017-2022 ($ Millions)
Figure 56. Russia Methylphenidate Revenue Growth 2017-2022 ($ Millions)
Figure 57. Middle East & Africa Methylphenidate Sales Market Share by Country in 2021
Figure 58. Middle East & Africa Methylphenidate Revenue Market Share by Country in 2021
Figure 59. Egypt Methylphenidate Revenue Growth 2017-2022 ($ Millions)
Figure 60. South Africa Methylphenidate Revenue Growth 2017-2022 ($ Millions)
Figure 61. Israel Methylphenidate Revenue Growth 2017-2022 ($ Millions)
Figure 62. Turkey Methylphenidate Revenue Growth 2017-2022 ($ Millions)
Figure 63. GCC Country Methylphenidate Revenue Growth 2017-2022 ($ Millions)
Figure 64. Manufacturing Cost Structure Analysis of Methylphenidate in 2021
Figure 65. Manufacturing Process Analysis of Methylphenidate
Figure 66. Industry Chain Structure of Methylphenidate
Figure 67. Channels of Distribution
Figure 68. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...